-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster II

Symposia: Hodgkin Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Ryan C. Lynch, MD1, Ryan D. Cassaday, MD1, Stephen D. Smith, MD1, Andrew J. Cowan, MD1, Edus H. Warren, MD, PhD1, Mazyar Shadman, MD, MPH2, Brian G. Till, MD3, Chaitra S. Ujjani, MD1, Karolyn Morris1*, Heather Rasmussen1*, Jenna M. Voutsinas, MPH1* and Ajay K. Gopal, MD1

1Fred Hutchinson Cancer Center, Seattle, WA
2Fred Hutchinson Cancer Research Center, Seattle, WA
3Fred Hutchinson Cancer Center, University of Washington, Seattle, WA

Paul J. Bröckelmann, MD1*, Sophie Teesink2*, Lydia Visser2*, Conrad-Amadeus Voltin, MD3*, Helen Kaul, Dipl.-Math.4*, Hans Schlösser5*, Bart-Jan Kroesen6*, Carsten Kobe, MD3*, Peter Borchmann, MD1, Arjan Diepstra2 and Wouter Plattel, MD, PhD7*

1University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
2Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
3Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
4Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
5Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
6Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
7Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Bruce D. Cheson1,2, Nancy L. Bartlett, MD3,4,5,6, Betsy R. LaPlant, MS7*, Hun Ju Lee, MD8, Ranjana H. Advani, MD9,10,11,12,13, Beth Christian, MD14, Catherine S. Diefenbach, MD15,16, Tatyana Feldman, MD17 and Stephen M. Ansell, MD, PhD18

1American Oncology Partners PA, Bethesda, MD
2American Oncology Partners PA, North Bethesda, MD
3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
4Division of Oncology, Washington University School of Medicine, St. Louis, MO
5Siteman Cancer Center, Washington University, St. Louis, MO
6Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
7Mayo Clinic, Rochester, MN
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Stanford Cancer Institute, Stanford University, Stanford, CA
10Stanford University, Stanford, CA
11Stanford Cancer Institute, Stanford, CA
12Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
13Division of Oncology, Stanford University Institute, Stanford, CA
14Division of Hematology, The Ohio State University, Columbus, OH
15New York University, Perlmutter Cancer Center at NYU Langone Health, New York, NY
16Perlmutter Cancer Center at NYU Langone Health, New York, NY
17Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
18Division of Hematology, Mayo Clinic, Rochester, MN

Andrew Bruce McDonald, MBChB1, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD2, Manuel Gotti3*, Antonio Pinto4*, Jan M. Zaucha5*, Vladimir Ivanov, MD6*, Vladimir Melnichenko7*, Heidi Mocikova, MD8*, Muhit Ozcan, MD9, Caterina Patti10*, João Farias11*, Iara Zapparoli Goncalves, MD12*, Olha Kuchkova13*, Jiri Mayer, MD14,15, Güray Saydam, MD16*, Sarah Tomassetti17*, Kumudu Pathiraja18*, Katherine Ryland, PhD18, Rushdia Yusuf18 and Wojciech Jurczak, MD, PhD19

1Alberts Cellular Therapy, Netcare Pretoria East Hospital, Pretoria, South Africa
2University of Cape Town, Cape Town, South Africa
3Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
5Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland
6Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation
7Pirogov National Medical Surgical Center, Moscow, Russian Federation
8Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
9Hematology Department, Ankara University School of Medicine, Cankaya-Ankara, Turkey
10Onco-Hematology Unit, Azienda Ospedaliera Riunita Villa Sofia-Vincenzo Cervello, Palermo, Italy
11Hospital Erasto Gaertner, Curitiba, Brazil
12Fundação Pio XII-Hospital de Câncer de Barretos, São Paulo, Brazil
13Kharkiv National Medical University, Kharkiv, Ukraine
14Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
15Masaryk University, Brno, Czech Republic
16Department of Internal Diseases, Division of Hematology, Ege University Medical Faculty Hospital, Izmir, Turkey
17Division of Hematology and Oncology, Harbor-UCLA Medical Center, Torrance, CA
18Merck & Co., Inc., Rahway, NJ
19MSC National Research Institute of Oncology, Kraków, Poland

Qingqing Cai, PhD1, Yi Xia, M.D, PhD1*, Xiaojie Fang, M.M1*, Man Nie, M.D, PhD1*, Qihua Zou, M.D, PhD1*, Jun Cai, M.D, PhD1*, Yuchen Zhang, M.D, PhD1*, Qiuyi Yang1*, Dawei Ding2*, Wen Wang2* and Xunqiang Wang2*

1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
2Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China

Chirag Trivedi, MD, DM1*, Sujith Kumar, MD, DM2*, Sushil Selvarajan, MD, DM2*, Sharon Anbumalar Lionel, MD, DM2*, Anup J Devasia, MD, DM3*, Fouzia N., MD, DM2*, Uday Kulkarni, MD, DM4, Aby Abraham, MD, DM4*, Alok Srivastava, MD, FRACP, FRCPA, FRCP4, Biju George, MD, DM4, Vikram Mathews, MD, DM5 and Anu Korula, MD, DM, MRCP2*

1Clinical Hematology and Bone Marrow Transplant, Christian Medical College and Hospital, Ludhiana, India
2Department of Haematology, Christian Medical College, Vellore, India
3Department of Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
5Department of Haematology, Christian Medical College Vellore, Ranipet Campus, India

Anna Maria Sureda Balarí, MD, PhD1, Javier Nuñez Cespedes, MD2*, María José Terol Castera3*, Francisca Maria Hernandez, MD4*, Eva Domingo Domenech, MD5*, Fatima De la Cruz Vicente, MD6*, Miram Moreno7*, Elena Amutio8*, Ana Pilar Gonzalez, MD9*, Raul Cordoba, MD, PhD10, Maria Carmen Martinez Munoz, MD, PhD11*, Samuel Romero, MD12*, Mariana Bastos-Oreiro13*, Antonia Rodriguez Izquierdo14*, Javier Briones15*, Richard Greil16*, Maria Casanova Espinosa17*, Araceli Rubio, MD18*, Irit Avivi19*, Raquel Del Campo20*, Pilar Gómez21*, Theodoros P. Vassilakopoulos, MD, PhD22*, Sandra Bašić-Kinda, MD, PhD23*, Sotiros Papageorgiou24*, Victor Noriega Concepcion, MD, PhD25*, Jose Sanchez Blanco26*, Blanca Sánchez-González27*, Izaskun Zeberio28* and Ramon García29*

1Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
2Hospital Universitario Marqués de Valdecilla, Santander, Spain
3Hospital Clínico Universitario INCLIVA, Valencia, ESP
4Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain
5Hospital Duran i Reynals, Institut Catala d’Oncologia, Hospitalet de Llobregat, Barcelona, Spain
6Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
7Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
8Osakidetza, Bilbao, Spain
9Hospital Universitario Central de Asturias, Oviedo, Spain
10Hematology Department, Health Research Institute IIS-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
11Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
12Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
13Hospital General Universitario Gregorio Marañón, Madrid, Spain
14Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
15Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
16IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseses and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
17Hematology, Hospital Costa del Sol, Malaga, Spain
18Hematology Department, Hospital Miguel Servet, Zaragoza, Spain
19Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
20Hematology Department, Hospital Universitario Son Llàtzer, Palma de Mallorca, ESP
21Hospital La Paz, Madrid, Spain
22Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
23Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
24University General Hospital Attikon, Athens, Greece
25Complejo Hospitalario Universitario ACoruña, A Coruña, ESP
26Hospital Morales Messeguer, Murcia, ESP
27Hematology Department, Hospital del Mar, Barcelona, Spain
28Hematology Department, Hospital Universitario Donostia, San Sebastian, ESP
29Hematology, General Universitary Hospital Gregorio Marañón, Madrid, Spain

Hishan Tharmaseelan, MD1*, Janina Jablonski1*, Ina Bühnen, MSc1*, Johannes Rosenbrock, MD2*, Paul J. Bröckelmann, MD1,3*, Justin Ferdinandus, MD4* and Peter Borchmann, MD1

1University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
2Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
3Max Planck Institute for Biology of Ageing, Cologne, Germany
4University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Cologne, Germany

Ryan C Lynch, MD1, Stefan K. Alig, MD2, Chaitra S. Ujjani, MD1, Christina Poh, MD1, Edus H. Warren, MD, PhD1, Stephen D. Smith, MD1, Mazyar Shadman, MD, MPH1, Brian G. Till, MD3, Vikram Raghunathan, MD1*, Yolanda D Tseng, MD4*, Susan Ottemiller1*, Bonnie Joy1*, Melissa Mary Fessel, ANP, BSN, RN1*, Hongyan Du1*, Jacquelin Vandermeer, BS1*, Alyssa Kelly1*, Heather Rasmussen1*, Jenna M. Voutsinas, MPH5*, Ash A. Alizadeh, MD, PhD6 and Ajay K. Gopal, MD1

1Fred Hutchinson Cancer Center, Seattle, WA
2Stanford University, Stanford, CA
3Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
4Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
6Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

Joseph Maakaron, MD1, Dipenkumar Modi, MD2, Matthew Mei, MD3, Tatyana Feldman, MD4, Gunjan L. Shah, MD5, Amitkumar N. Mehta, MD6, Craig S. Sauter, MD7, Rashmi Khanal, MD8, Stefan K. Barta, MD9, Michael Emig, MD10,11*, Lydia Wunderle, MD11*, Andre Overesch10*, Alexandra Vasile, PhD12*, Jennifer Rubel13*, Thorsten Graef, MD14*, Heather Raymon, PhD15* and Alison Moskowitz, MD5

1Division of Hematology, Oncology and Transplantation, Department of Medicine, Masonic Cancer, University of Minnesota, Minneapolis, MN
2Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
3City of Hope Medical Center, Duarte, CA
4Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ
5Memorial Sloan Kettering Cancer Center, New York, NY
6O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
7Department of Hematology and Medical Oncology Cleveland Clinic, Cleveland, OH
8Fox Chase Cancer Center, Philadelphia, PA
9Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA
10Affimed GmbH, Heidelberg, Germany
11Affimed GmbH, Mannheim, Germany
12Affimed GmBH, mannheim, Germany
13Affimed Inc., New York
14Artiva Biotherapeutics, Inc., San Diego, CA
15Artiva Biotherapeutics, Inc., San Diego

Robert Stuver, MD1, Santosha A. Vardhana, MD, PhD1, Nivetha Ganesan, MPH2*, Alexander P. Boardman, MD1*, Philip Caron, MD1, Tiffany Chang, MS2*, Kevin A. David, MD1*, Zachary D. Epstein-Peterson, MD1, Lorenzo Falchi, MD2, Paola Ghione, MD, MSEpi2, Paul A. Hamlin, MD1, Francisco Hernandez-Ilizaliturri, MD3, Steven Horwitz, MD1, Andrew M. Intlekofer, MD, PhD1, William T. Johnson, DO4, Reem Karmali, MD5, Jennifer Kimberly Lue, MD1, Anita Kumar, MD6, Efrat Luttwak, MD1, Neena Mahajan2*, Amira Marouf, MD, PhD2, Ariela Noy, MD1, Colette Owens, MD1, Maria Lia Palomba, MD1, Gilles Salles, MD, PhD7, Heiko Schoder, MD2*, David Sermer8*, Venkatraman Seshan2*, Raphael E. Steiner, MD2, Pallawi Torka, MD9, Andrew D. Zelenetz, MD, PhD1, Gottfried von Keudell, MD, PhD10 and Alison Moskowitz, MD1

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
7Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
8AstraZeneca, New York, NY
9MSKCC, New York, NY
10Beth Israel Deaconess Medical Center, Boston, MA

Paul J. Bröckelmann, MD1*, Boris Böll, MD2*, Daniel Molin3*, Gundolf Schneider, MSc4*, Sirpa Leppä, MD, PhD5, Julia Meissner, MD6*, Peter Kamper, MD, PhD7*, Martin Hutchings, MD, PhD8, Jacob Haaber Christensen, MD, PhD9*, Ulf Schnetzke10*, Michael Fuchs, MD4*, Dennis A Eichenauer, MD4*, Bastian von Tresckow11, Helen Kaul, Dipl.-Math.4*, Peter Borchmann, MD1 and Alexander Fossa, MD12*

1University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
2Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne; equal contribution, Cologne, Germany
3Oncology Department, Uppsala University, Uppsala, Sweden
4Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
5Department of Oncology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
6Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
7Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
8Department of Hematology, Rigshospitalet, Copenhagen, Denmark
9Dept. of Hematology, Odense University Hospital, Odense, Denmark
10Hematology and Medical Oncology, University Hospital Jena, Jena, Germany
11Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
12Department of Oncology, Oslo University Hospital, Oslo, Norway

Christine Mauz-Koerholz, MD1,2, Luciana Vinti, PhD3, Stephen Daw4*, Antony Ceraulo5*, Gerard Michel, MD, PhD6*, Michaela Cepelova7*, Lorena Valero-Arrese8*, Franca Fagioli, MD, PhD9,10*, Stéphane Ducassou11*, Salvatore Buffardi12*, Thierry Leblanc13*, Bradford S Hoppe, MD, MPH14*, Frank G. Keller15*, Kara M. Kelly, MD16, Lisa Giulino Roth, MD17, Judith Landman-Parker18*, Juan Shen19*, Pallavi Pillai, MD19, Rushdia Yusuf19 and Auke Beishuizen, MD20

1Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Halle, Germany
2Justus-Liebig University of Giessen, Giessen, Germany
3IRCCS Ospedale Pediatrico Bambino Gesú, Rome, Italy
4University College London Hospitals NHS Foundation Trust, London, United Kingdom
5'Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe), Lyon, France
6CHU de Marseille Hôpital de la Timone Enfants, Marseille, France
7University Hospital Motol and 2nd Medical Faculty Charles University, Prague, Czech Republic
8Hospital Universitari Vall d’Hebron, Barcelona, Spain
9Ospedale Infantile Regina Margherita, Turin, Italy
10University of Turin, Turin, Italy
11CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France
12Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy
13Hôpital Universitaire Robert-Debré, Paris, France
14Mayo Clinic, Jacksonville, FL
15Children's Healthcare of Atlanta at Egleston, Atlanta, GA
16Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY
17Weill Cornell Medicine, New York, NY
18Sorbonne Université APHP Hôpital Armand Trousseau, Paris, France
19Merck & Co., Inc., Rahway, NJ
20Princess Máxima Centre, Utrecht, Netherlands

*signifies non-member of ASH